"In order to provide a viable near-term solution for the CSG industry in Queensland, Parkway is
developing standard designs incorporating modular equipment, based on Parkway’s proprietary
upstream brine concentration and beneficiation process. Preliminary internal evaluations suggest QBS
is likely to be able to provide a highly attractive brine concentration service (lower cost, better outcome)
to CSG companies on a toll-treatment basis. Given the calibre of potential counterparties, the
anticipated high rates of return, and the scale of the upstream plants, Parkway expects to be able to
potentially build, own and operate (BOO) these projects, potentially with partner/s, depending on project
specific parameters".
Whether the CSG companies choose encapsulation or the masterplan they need to concentrate and crystalise the brine. I assume modular means these plants can be readily relocated. If they are the most efficient option for dewatering it seems like a pretty good idea.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
"In order to provide a viable near-term solution for the CSG...
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PWN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.20M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $2.258K | 188.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2762841 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 0.011 |
13 | 4434212 | 0.010 |
9 | 3812394 | 0.009 |
9 | 2391000 | 0.008 |
10 | 5468548 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2762841 | 3 |
0.013 | 2912087 | 5 |
0.014 | 307441 | 3 |
0.015 | 2075892 | 6 |
0.016 | 2758482 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PWN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online